CRISPR Could Yield $25B in Revenues by 2030 – hcanews.com
|
CRISPR Could Yield $25B in Revenues by 2030
hcanews.com Companies using applications of Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) genome-editing technology might rake in as much as $25 billion in revenues by the 2030s, according to a new analysis from Frost & Sullivan, the respected … Frost & Sullivan Projects CRISPR Technology Will Be Fastest Growing Gene Editing Market Segment |
